Novavax, Inc. (NASDAQ:NVAX) does about 15.65M shares in volume on a normal day but saw 10098159 shares change hands in Friday trading. The company now has a market cap of 1.78B USD. Its current market price is $12.66, marking a decrease of -1.33% compared to the previous close of $12.83. The 52 week high reached by this stock is $23.86 whilst the lowest price level in 52 weeks is $3.53.
Novavax, Inc. (NVAX) has a 20-day trading average at $15.51 and the current price is -46.94% off the 52-week high compared with 258.40% distance from its 52-week low. The 50-day simple moving average of the closing price is $11.55 and its 200-day simple moving average is $6.99. If we look at the stock’s price movements over the week, volatility stands at 5.66%, which increases to 10.43% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 42.72 to suggest the stock is neutral.
The consensus objective for the share price is $22.80, suggesting that the stock has a potential upside of 44.47% over the period.
BofA Securities also upgraded the stock to “Neutral” from Underperform on May 10, 2024 at a price target of $4-$12. B. Riley Securities upgraded its price target at $15.
Novavax, Inc. (NVAX) stock is down -9.57% over the week and -16.21% over the past month. Its price is 163.75% year-to-date and 68.13% over the past year.
To reach the target analysts have set, the stock logically needs to grow 44.47 percent from here.
The beta has a value of 1.96. Price to sales ratio is 1.78.
